연구성과로 돌아가기
2021 연구자 정보 (38 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Heo, Mi Hwa (Heo, MH) |
Keimyung Univ, Dept Internal Med, Div Hematooncol, Dongsan Hosp, Daegu, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Hotko, Yevhen (Hotko, Y) |
F-9068-2019 Hotko, Yevhen |
0000-0002-4533-4210 Hotko, Yevhen |
[JCR상위 2.2] Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane. | SCIE | 2.2 | ONCOLOGY | ||||
|
Jang, You Jin (Jang, YJ) |
Korea Univ, Dept Surg, Guro Hosp, Seoul, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Jung, Mi Ran (Jung, MR) |
Chonnam Natl Univ, Dept Surg, Med Sch, Hwasun, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kim, Beom Su (Kim, BS) |
Univ Ulsan, Asan Med Ctr, Dept Surg, Seoul, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kim, Gyunji (Kim, G) |
Sanofi Korea, Seoul, South Korea |
ABD-7016-2020 Kim, Yuriy |
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kim, Hark Kyun (Kim, HK) |
Natl Canc Ctr, Ctr Gastr Canc, Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kim, Hyun Ki (Kim, HK) |
Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea |
|
0000-0003-2292-5584 Kim, Hyunki |
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kim, Sohyun (Kim, S) |
|
|
[JCR상위 2.2] Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial. | SCIE | 2.2 | ONCOLOGY | ||||
|
Kook, Myeong-Cherl (Kook, MC) |
Natl Canc Ctr, Ctr Gastr Canc, Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea |
B-7001-2014 Kook, Moochang |
0000-0002-3435-3301 Kook, Myeong-Cherl |
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Kumar, Akshi (Kumar, A) |
Delhi Technol Univ, New Delhi, India |
Y-9314-2019 Kumar, Akshi |
0000-0003-4263-7168 Kumar, Akshi |
[JCR상위 2.2] Social, mobile, analytic and cloud technologies: Intelligent Computing for future smart cities | SCIE | 2.2 | CONSTRUCTION & BUILDING TECHNOLOGY;ENERGY & FUELS;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY | anandnayyar@duytan.edu.vn;sara.paiva@estg.ipvc.pt;Paul.editor@gmail.com;akshikumar@dce.ac.in; | ||
|
Lee, Jong Seok (Lee, JS) |
Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Lee, Keun Wook (Lee, KW) |
JQV-8143-2023 Lee, Juhyung |
|
[JCR상위 2.2] Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16). | SCIE | 2.2 | ONCOLOGY | ||||
|
Lee, Kyung-ha (Lee, KH) |
|
|
[JCR상위 2.2] Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial. | SCIE | 2.2 | ONCOLOGY | ||||
|
Lee, Nam Su (Lee, NS) |
Soon Chun Hyang Univ Hosp, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; |
페이지 이동: